PhRMA’s Office of Accountability is responsible for receiving comments from the general public and health care professionals regarding Direct to Consumer (DTC) advertisements conducted by any signatory company to the PhRMA Guiding Principles on Direct to Consumer Advertisements About Prescription Medicines.
The Office of Accountability reports periodically on the nature of the comments and the companies’ response, and provides copies of these reports to the FDA.
Read the latest report issued by the Office of Accountability.
Procedures for Sending Comments to the Office of Accountability
If you would like to submit a comment to the PhRMA Office of Accountability about a particular DTC advertisement, please follow these steps:
- The Office can only accept comments submitted via the web form link here.
- The comment should provide information sufficient to identify the company and/or DTC advertisement at issue.
- The comment should relate in some way to an aspect of DTC advertising covered by the Principles. Please be sure to include a working email or physical address so the Office of Accountability can acknowledge receipt of your comment.
If your comment relates to an aspect of a signatory company’s advertising that is covered by the Principles, the Office of Accountability will forward your comment to the relevant company for consideration.